Invasive Fungal Infections Among Ventilated HSCT Patients in the ICU
Invasive fungal infection (IFI) is associated with high morbidity and high mortality in hematopoietic stem cell transplantation (HSCT) patients. Chen-Yiu Hung, of the Department of Thoracic Medicine at Chang Gung Memorial Hospital in Taipei, Taiwan, and colleagues, sought to assess the characteristics and outcomes of HSCT patients with IFIs who are undergoing mechanical ventilation (MV) at a single institution in Taiwan.
Â
The researchers performed an observational retrospective analysis of IFIs in HSCT patients undergoing MV in an intensive care unit (ICU) from 2000 to 2009. The characteristics of these HSCT patients and risk factors related to IFIs were evaluated. The status of discharge, length of ICU stay, date of death and cause of death were also recorded.
Â
There were 326 HSCT patients at the Linkou Chang-Gung Memorial Hospital (Taipei, Taiwan) during the study period. Sixty of these patients (18 percent) were transferred to the ICU and placed on mechanical ventilators. A total of 20 of these 60 patients (33 percent) had IFIs. Multivariate analysis indicated that independent risk factors for IFI were admission to an ICU more than 40 days after HSCT, graft versus host disease (GVHD), and high dose corticosteroid (p < 0.01 for all). The overall ICU mortality rate was 88 percent (53 of 60 patients), and was not significantly different for patients with IFIs (85 percent) and those without IFIs (90 percent, p = 0.676).
The researchers concluded that there was a high incidence of IFIs in HSCT patients requiring MV in the ICU in their study cohort. The independent risk factors for IFI are ICU admission more than 40 days after HSCT, GVHD, and use of high-dose corticosteroid. Their research was published in BMC Infectious Diseases.
Reference: Hung C-Y, et al. Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit. BMC Infectious Diseases 2012, 12:44 doi:10.1186/1471-2334-12-44
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
